µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© d "25e"(~F
w d6+,B
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© NUh+ &M
1¡¢Co-stimulators (or co-stimulating molecules) ^*b11/7
2¡¢NK-kB |%uy{
3¡¢Immunoglobulin superfamily wQYW5X
4¡¢antigen-presenting cell (APC) -'T^gEd)c
5¡¢death domain |xrnLdng0R
6¡¢CCR and CXCR |y4j:`@.
7¡¢Lectin (or mitogen) , 8o
Y(h
8¡¢Clusters of differentiation, CD) 5%w08
9¡¢B7 family d
9]zB-A
10¡¢Cytotoxic T lymphocyte, CTL) B#4'3Y-3
11¡¢IL-15 and IL-15 receptor (IL-15R) .9q`Tf
12¡¢MHC restriction VBz
G`&NG
13¡¢Affinity-chromatography V`}u:t7r
14¡¢Cyctosprin A, CsA n&8SB'-r
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) W!JEl|]
9>=S@hVMd
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© ^GNL:D%6d
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 n$<n
Yr`X
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ _% i!LyG
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 ut.tf \c
~R~eQ=8
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© $`<-;kI
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ {}P~nP
ѪҺ²¡Ñ§×¨Òµ£º 5Q,j+
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿